Clinical Trials Directory

Trials / Completed

CompletedNCT01831284

Correlates and Consequences of Increased Immune Activation in Injection Drug Users

Status
Completed
Phase
Study type
Observational
Enrollment
201 (actual)
Sponsor
Rockefeller University · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to learn how injection drug use may affect the immune system.

Detailed description

The goal of this study is to learn how injection drug use may affect the immune system. One way to measure this is by looking at the blood and the gut, or gastrointestinal tract at the same time. It is thought that activating the immune system by injection drug use may increase destruction of immune cells in the gut. To test this theory, the investigators are enrolling HIV-negative injection drug users, HIV-negative people who do not use drugs and HIV-negative former injection drug users.

Conditions

Interventions

TypeNameDescription
PROCEDURESigmoidoscopy with biopsySigmoidoscopy with biopsy

Timeline

Start date
2012-12-01
Primary completion
2014-09-01
Completion
2014-09-01
First posted
2013-04-15
Last updated
2014-11-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01831284. Inclusion in this directory is not an endorsement.

Correlates and Consequences of Increased Immune Activation in Injection Drug Users (NCT01831284) · Clinical Trials Directory